Marani Health Wins FDA Clearance for M•care System
Minneapolis, Minnesota, U.S., September 24, 2026 Marani Health has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Minneapolis, Minnesota, U.S., September 24, 2026 Marani Health has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Sunnyvale, California, September 23, 2026 GRAIL, Inc. announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics...
London, United Kingdom, September 22, 2026 Smith+Nephew has announced U.S. FDA 510(k) clearance for its LANDMARKâ„¢ Total Knee System...
Miami Lakes, Florida, U.S., September 21, 2026 Cordis has announced that the U.S. Food and Drug Administration (FDA) has...
India, September 18, 2026 Concept Medical is highlighting new subgroup findings from the SirPAD randomized clinical trial that will...
Atlanta and Carlsbad, California, September 20, 2026 Field Medical, Inc. has announced publication of 12-month results from its first-in-human...
Carlsbad, California, USA, September 17, 2026 Aptitude Medical Systems has announced that the U.S. Food and Drug Administration (FDA)...
Boston, Massachusetts, U.S., September 15, 2026 ReEmerge, Inc. has emerged from stealth with an oversubscribed $37 million Series A...
Waltham, Massachusetts, U.S., September 15, 2026 Lumicell, Inc. is expanding the commercial use of LumiSystem®, its fluorescence-guided imaging platform...
Caesarea, Israel, September 15, 2026 Nitinotes has announced the completion of the first EASEâ„¢ clinical trial procedures at Fondazione...
